← All stocks

Organogenesis Holdings Inc.

ORGO No buying or selling

CIK 0001661181 #3789 in the set updated 21 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

18 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Ades Alan A.

Director

—

102,170,804

$272.67M

+18.9%

ERANI ALBERT

10% owner

—

51,585,403

$137.67M

−22.3%

GN 2016 Family Trust u/a/d August 12, 2016 entity

10% owner

—

51,085,403

$136.34M

−1.9%

Gillheeney Gary S.

President and CEO

—

4,231,112

$11.29M

+79.9%

NUSSDORF GLENN H

Director

—

2,901,310

$7.74M

−5.4%

Bilbo Patrick

Chief Operating Officer

—

1,127,985

$3.01M

+39.4%

Freedman Lori

Chief Admin. and Legal Officer

—

1,023,355

$2.73M

+118.1%

Grow Brian

Chief Commercial Officer

—

899,355

$2.40M

+73.0%

Francisco David

Chief Financial Officer

—

731,020

$1.95M

+70.4%

Leibowitz Arthur S

Director

—

291,014

$776.66K

+55.1%

Cavorsi Robert

Vice President, Strategy

—

275,524

$735.32K

+97.0%

Duraibabu Prathyusha

Director

—

247,047

$659.32K

+66.2%

Giacomin Jon L

Director

—

241,026

$643.25K

+69.0%

Quintero Gilberto

Director

—

239,073

$638.04K

+70.0%

Korfin Michele Ilene

Director

—

239,073

$638.04K

+70.0%

Montecalvo Antonio S.

Vice President, Health Policy

—

226,163

$603.58K

+34.4%

Driscoll Michael Joseph

Director

—

225,707

$602.37K

+58.6%

Lustig Garrett

Director

—

125,742

$335.58K

+359.9%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Organogenesis Holdings Inc.

By person

Individual transactions

What was left out